MTAP and prostate cancer: However, Bistulfi et al. [15] did not find evidence for MTAP expression loss in 13 cell lines and 75 clinical samples of prostate cancer but reported evidence for an important functional role of MTAP in prostate cancer cells including a blockade of androgen sensitive prostate cancer growth by MTAP inhibition in vitro and in vivo.